[Ongoing Program] Life Sciences Dealmaking Symposium 2020 - Part 2 - October 27th, 12:00 pm - 1:00 pm EDT

McDermott Will & Emery

October 27th, 2020
12:00 PM - 1:00 PM EDT
$ 199.00

KEYNOTE SPEAKERS

SCOTT GOTTLIEB, M.D.

Immediate Past Commissioner Food and Drug Administration (2017-2019); Former Senior Advisor – CMS

DR. MICHELLE MCMURRY-HEATH

President & CEO,
Biotechnology Innovation Organization

In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to bringing innovations to market.

Join us virtually for our signature Life Sciences Dealmaking Symposium, where seasoned dealmakers, industry executives and technical experts come together with McDermott's leading life sciences lawyers. Beginning October 20, we'll bring you a series of three pre-Symposium programs focused on today's most pressing concerns for life sciences dealmakers, all culminating in a half-day virtual program with multiple networking sessions, industry-leading keynote speakers and insights from investors, life sciences executives, policy experts and investment bankers.

PROGRAM DETAILS

PRE-SYMPOSIUM WEBINARS

Part 1: Tuesday, October 20, 12:00 – 1:00 pm EDT

  • New Factors in the Mix: Diligence in the Time of COVID-19

Moderator:
Michael Siekman

Partner, McDermott Will & Emery

Anna French
Principal, Qiming Venture Partners

Tom Brida
General Counsel, Chief Compliance Officer, Invitae

Jennifer Bock
Attorney, McDermott Will & Emery

Laura Jehl
Global Head of Privacy and Cybersecurity Practice, McDermott Will & Emery

Chuck Wilson
President and CEO, Cogent Biosciences

Part 2: Tuesday, October 27, 12:00 – 1:00 pm EDT

  • Powering Through the Pandemic: Trends in Early Stage Investment

Moderator:
Todd Finger

Partner, McDermott Will & Emery

Joanna Lin
Partner, McDermott Will & Emery

Marian Nakada
Vice President, Venture Investment, J&J Innovation

Andrew ElBardissi
Partner, Deerfield Management

Stacey Seltzer
Partner, Aisling Capital

Part 3: Tuesday, November 10, 12:00 – 1:00 pm EST

  • As the Dust Settles: Post Election Update and Impact on the Life Sciences Industry

Moderator:
Eric Zimmerman

Global Head of Health Practice, McDermott Will & Emery

Rodney Whitlock, Ph.D.
Vice President, McDermott+Consulting

Brian Fortune
Senior Managing Director, Farragut Square Group

Susan van Meter
Executive Director, AdvaMedDx

Virtual Life Sciences Dealmaking Symposium: Tuesday, November 17, 8:00 am – 2:00 pm EST

*Networking platform will be open from 8:00 am - 6:00 pm EST*

AGENDA:

8:00 - 9:45 am

Pre-event Networking

9:30 – 9:35 am

Welcome Remarks
Krist Werling, Co-Chair, Life Sciences Industry Group, McDermott Will & Emery

9:35 – 10:00 am

Michelle McMurry-Heath Keynote
President and CEO, Biotechnology Innovation Organization

10:00 – 10:40 am

M&A Outlook: Expect the Unexpected
Moderator: Byron Kalogerou, Partner, McDermott Will & Emery
Dennis Crowley, Senior Vice President, Business Development & Licensing, Baxter
Patrice McNicoll, Co-head of Investment Banking, B. Riley Financial

10:40 – 11:10 am

Sight Unseen: Cross-border Collaboration Goes Virtual
Moderator: Emmanuelle Trombe, Partner, McDermott Will & Emery
Rich Smith, Partner, McDermott Will & Emery

11:10 – 11:15 am

Bio Break

11:15 – 11:45 am

Speed vs. Safety: Innovating with Urgency in Diagnostics & Vaccines
Moderator: Brian Malkin, Partner, McDermott Will & Emery
Steve Bossone, Senior Vice President, Chief Patent Counsel, Alnylam
Sarah Columbia, Partner, McDermott Will & Emery
Michael Ryan, Partner, McDermott Will & Emery
Alan Wright, Chief Medical Officer, Roche Diagnostics

11:45 am – 12:15 pm

Digital Health Takes Center Stage: Will It Be The Hottest Sector for Dealmaking
Moderator: Stephen Bernstein, Co-Chair, Life Sciences Industry Group, McDermott Will & Emery
Kathy Bergsteinsson, Managing Director, Morgan Stanley
Jennifer Geetter, Partner, McDermott Will & Emery
Debbie Lin, Executive Director, Boehringer Ingelheim Venture Fund
Rene Quashie, Vice President, Policy and Regulatory Affairs, Digital Health, Consumer Technology Association

12:15 – 12:45 pm

Racial Justice in the Start-up Sector: the McDermott RISE Program
Moderator: Vernessa Pollard, Chair, FDA Practice, McDermott Will & Emery
Marshall Jackson, Partner, McDermott Will & Emery
Nathan Pelzer, CEO, Clinify Health
Kwame Ulmer, Founder, MedTech Color

12:45 – 1:30 pm

Scott Gottlieb Keynote
Immediate Past Commissioner Food and Drug Administration (2017-2019); Former Senior Advisor – CMS

1:30 – 2:00 pm

Post-event Networking

View Full Agenda (Coming Soon)

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDermott Will & Emery | Attorney Advertising

PRESENTED BY:

McDermott Will & Emery
Contact
more
less

McDermott Will & Emery on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.